BioSpace News Archive

Global molecular diagnostics innovator, Sense Biodetection, announced receipt of CE Marking for Veros COVID-19, the first and only fully integrated, easy-to-use molecular diagnostic test that provides laboratory-quality results in 15 minutes.

Ixaka Ltd, an integrated cell and gene therapy company, announces that Advanced Therapy Medicinal Product classification has been granted by the European Medicines Agency for its Chemically Encapsulated Lentiviral vector for Targeted In Vivo CAR T-cell therapy targeted nanoparticle product.

AlzeCure Pharma AB announced new indicative data from the ongoing clinical phase I MAD study with ACD856 showing that the substance reaches the brain, the target organ for the substance which is developed as a treatment for Alzheimer’s disease.

MannKind Corporation announced that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a virtual presentation at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 4:00 pm.

Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, reported financial and operating results for the fourth quarter and year ended December 31, 2021.

Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will present a corporate overview during the Barclays Global Healthcare Conference.

Enanta Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference.

VUZE Medical has received additional patents for its VUZE™ System in the U.S., Europe and China.

PureTech Founded Entity Akili Named to Fast Company ’s Annual List of the World’s 50 Most Innovative Companies for 2022.

Aptose Biosciences Inc. will report financial results for the year and quarter ended December 31, 2021, on Tuesday, March 22, 2022 after the close of the market, and provide a corporate update.